Novavax
NVAX
NVAX
129 hedge funds and large institutions have $174M invested in Novavax in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 38 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.24M
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Holders
129
Holding in Top 10
–
Calls
$1.09M
Puts
$1.24M
Top Buyers
| 1 | +$26.8M | |
| 2 | +$4.48M | |
| 3 | +$2.27M | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.56M |
| 5 |
Millennium Management
New York
|
+$1.5M |
Top Sellers
| 1 | -$8.79M | |
| 2 | -$4.7M | |
| 3 | -$3.37M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$2.31M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.83M |